https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/women

The Latest

Senior woman receives prescription medication from doctor

Should All PrEP Users on Truvada Switch to Descovy? These Leading Docs Say, ‘Not So Fast.’

Many fear the push to put more people on the new brand-name drug before Truvada goes generic this year.

long winding road through countryside

This Week in HIV Research: The Long Road to the End

Dec. 12, 2019: A lot of catchup to do before “Ending the HIV Epidemic”; the value of online HIV self-test distribution; viral suppression is about more than basic HIV treatment services; effect of hormone therapy on PrEP levels.

PrEP Posters

Black Women in Atlanta Need More PrEP Access. Researchers and Advocates Are Working to Make This a Reality.

While most pre-exposure prophylaxis (PrEP) campaigns focus on gay and bisexual men, Fulton County Board of Health officials and advocates look for solutions to get PrEP to black women.

Scientist holding slide with blood sample in lab

This Week in HIV Research: U=U Grows Ever Stronger

Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.

woman using facebook app on phone

Meet Young People on Their Own Terms and Don’t Judge Their Sex Lives, Experts Agree

Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.

Asa Radix at IAS 2019

Taking Transgender Care From Research to Results

Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.

young woman taking blue pill

Four PrEP Studies Address Challenges and Best Practices for Uptake and Retention

Four recent studies in JAIDS chiefly focused on PrEP provision to cisgender women and gay and bisexual men.

Ivana Beesham

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.